Swedish biotechnology firm Promore Pharma has completed the reverse acquisition of Cork medical devices company, PMD Solutions.
The deal saw Promore purchase all shares in PMD for approximately €11m, which was paid by newly-issued shares in the Stockholm-based firm.
Following the completion of the reverse acquisition, which was approved on December 29, the company has changed its name from Promore Pharma to PMD Device Solutions and the company’s ticker symbol will change from PROMO to PMDS on the Nasdaq Stockholm Exchange (Nasdaq…
